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Abstract
Background: Silica nanoparticles (SNPs) can easily enter in respiratory system via inhalation because of their low
molecular weight and ease of dispersion. Toxicity and adverse effects of SNPs vary according to the physical
characteristics of the particle.
Methods: To evaluate the toxic and adjuvant effects of 3 types of SNPs in the airway system, six-week-old female
BALB/c mice were intranasally administered 3 types of SNPs (spherical [S-SNP], mesoporous [M-SNP], and polyethylene
glycol-conjugated [P-SNP]) alone or SNPs/ovalbumin (OVA), three times weekly for 2 weeks. Airway hyper-responsiveness
(AHR), bronchoalveolar lavage fluid (BALF), cytokine levels, and histology of the lungs were analyzed.
Results: The S-SNPs/OVA group and M-SNPs/OVA group showed significant AHR, compared to the control group.
Among all SNP-treated groups, the group administered SNPs/OVA showed greater inflammatory cell infiltration in BALF,
extensive pathological changes, and higher cytokine levels (IL-5, IL-13, IL-1β, and IFN-γ) than those administered SNPs
alone or saline/OVA.
Conclusion: Exposure to SNPs alone and SNPs/OVA induced toxicity in the respiratory system. SNPs alone showed
significant toxic effects on the airway system. Meanwhile, SNPs/OVA exerted adjuvant effects to OVA of inducing
allergic airway inflammation. In particular, M-SNPs showed the most severe airway inflammation in both direct toxicity
and adjuvant effect assays. P-SNPs induced less inflammation than the other types of SNPs in both models.
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Background
Silica nanoparticles (SNPs) are among the most common
components found naturally in the earth’s crust [1].
SNPs are used in many engineering and medical fields
including fabrication, plastics, insulation materials, drug
delivery systems, cosmetics, food packing, and coating
processes [2]. SNPs are usually believed to be non-
cytotoxic and safe. Although SNPs have great import-
ance in nanotechnology, they also have a potential toxic
effect, resulting in a health problem. SNPs may both
stimulate and suppress the mouse and human immune
system and cause injury to cells of several organs [3–6].
SNPs are thought to have different toxic effects depend-
ing on their surface characteristics [7]. Many types of
SNPs have been developed and studied; spherical type
(S-SNP) is a standard form, mesoporous type (M-SNP)
has an extremely large surface area, and PEGylated type
(P-SNP) has modified surface with polyethylene glycol
(PEG). The contact and surface area of M-SNPs is the
largest among the three kinds of SNPs (M-SNPs,
70.6 m2/g; S-SNPs and P-SNPs, 12.7 m2/g). A recent
report suggested that the high surface area of SNPs may
be useful for drug delivery but also aggravate airway
inflammation in murine model and may have adverse
effects on human health [8, 9].
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Asthma is a chronic airway allergic disease character-
ized by airway hyper-responsiveness (AHR) and airway
inflammation [10]. The prevalence of asthma has been
rising recently in urban centers within industrialization
regions of Africa, Latin America and Asia [11]. This
increase in the prevalence of asthma is thought to be
induced by environmental contributors such as air pol-
lutants and nanomaterials [12, 13]. Due to their small
size, SNPs can easily enter the respiratory system via in-
halation. Exposure to SNPs in manufacturing, managing,
and packing through the use and discarding of SNPs
may aggravate respiratory diseases, such as asthma, aller-
gic rhinitis, and bronchitis [14]. However, it is not well
known whether SNPs exacerbate asthma in asthmatic
mouse model or induce adjuvant effects. Toxic effects of
SNPs in the airway system upon inhalation are seldom
investigated and the mechanism remains unclear. In
this study, we aimed to evaluate the toxic and adjuvant
effects of three types of SNPs in the mouse airway
system.
Methods
Silica nanoparticle preparation
SNPs of the spherical (S-SNP), mesoporous (M-SNP),
and PEGylated (Polyethylene glycol, P-SNPs) types were
provided by the Department of Chemical and Biomo-
lecular Engineering, Yonsei University [15]. SNPs were
diluted to stock solutions of SNPS as follows (S-SNP:
10.0 mg/ml, M-SNP: 29.5 mg/ml, P-SNP: 9.0 mg/ml)
in saline.
Characterization of SNPs
Transmission electron microscopy (TEM) was accom-
plished using a Tecnai 20 to measure the particle size of
SNPs (FEI Co., Eindkdk, USA). TEM was performed to
the general protocols for TEM study. The particle size of
SNPs showed about 100 nm (Fig. 1a–c). Dynamic Light
Scattering (DLS; Novato, CA, USA) analysis was used to
characterize the size, distribution, and aggregation of the
SNPs in diluted saline (Fig. 1d–f ). Surface area was
measured by Brunauer-Emmett-Teller (BET) equation
method. The average pore diameter of the M-SNPs was
calculated to be 3.0 nm using the Barrett-Joyner-
Halenda (BJH) method.
Measurement of endotoxin
Limulus Amebocyte Lysate (LAL) assay was used to meas-
ure endotoxin levels in SNPs and OVA at concentrations
of 1 mg/ml. The LAL assay kit was obtained from Lonza
(Walkersville, MD, USA). The detection limit was less
than 0.1 EU/ml.
Animals and treatments
Female BALB/c mice, 5–6 weeks old, were purchased
(Jungang Animal Experimental, Seoul, Korea). SNPs
alone and SNP/OVA model were used 5 mice for each
group. All mice were maintained at conventional animal
facilities under standard conditions (room temperature
of 21–24 °C and relative humidity of 45–70 %, with a
12 h light/dark cycle), and all experimental protocols
were approved by the Department of Laboratory Animal
Resources, Yonsei Biomedical Research institute, Yonsei
University College of Medicine. The present study was
approved by the guide for the care and use of laboratory
animal guide line. SNPs sized 100 nm were administered
via intranasal inoculation of 10 mg/kg per treatment
(SNP direct toxicity model, Experiment 1, Fig. 2a)
and SNPs 10 mg/kg per treatment and OVA 1 mg/kg
(SNP/OVA model, Experiment 2, Fig. 2b) (EndoFit
Ovalbumin, invivogen, USA) were administered 6 times
over 2 weeks.
Measurement of airway hyper-responsiveness
Airway hyper-responsiveness (AHR) in response to in-
haled aerosolized methacholine was measured using a
forced oscillation technique (FlexiVent®; SCIREQ,
Montreal, Canada) 48 h after the last challenge. A cannula
was inserted into anesthetized mice via tracheostomy,
and then the mice were connected to a ventilator.
Aerosolized normal saline (0.9 % NaCl) or methacho-
line (3.125, 6.25, 12.5, 25.0 and 50.0 mg/ml) was admin-
istered to the mice for 10 s via a nebulizer. AHR was
measured and continuously recorded for up to 2 min.
Collection of bronchoalveolar lavage fluid
To collect bronchoalveolar lavage fluid (BALF), lungs
were lavaged three times with 1 ml of Hank’s Balanced
Salt Solution (HBSS, Gibco, USA) through the tracheal
tube. The recovered BALF was centrifuged for 3 min
at 1,500 g and 4 °C. The whole cells were resuspended in
HBSS and the total number of cells was counted using a
hemocytometer. BALF cell smears were prepared by
cytocentrifugation (Cytospin 3, Thermo, Waltham, USA).
The slides were stained, and 100 inflammatory cells
including neutrophils, eosinophils, lymphocytes, and mac-
rophages were counted.
Measurement of cytokine levels
After collecting BAL fluid, the right lung was homog-
enized using tissue homogenizer (Biospec Products,
Bartlesville, USA) in 1.5 ml of RIPA buffer (Thermo,
IL, USA) and protease inhibitor solution (Sigma-aldrich).
After incubation for 30 min on ice, homogenates were
centrifuged at 14,000 x g for 20 min. Supernatants
were collected. Concentrations of interleukin-5 (IL-5)
(detection limit: 31.2 pg/ml), interleukin-13 (IL-13)
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(detection limit: 62.5 pg/ml), interleukin-1beta (IL-1β) (de-
tection limit: 15.6 pg/ml), and interferon gamma (IFN-γ)
(detection limit: 31.2 pg/ml) in lung homogenate
were measured by ELISA (R&D Systems, San Diego,
USA) according to the manufacturer’s instructions.
Histological analysis
After the collection of BALF, the other lung was fixed in
4 % formalin and embedded in paraffin. Lung sections
were cut (3 -4 μm) and stained with hematoxylin and
eosin (H&E) staining for general examination, periodic
acid-Schiff staining (PAS) to measure goblet cell hyper-
plasia. The number of goblet cells in selected bronchi
along the basement membrane was counted on PAS-
stained slides at 200× magnification; goblet cell numbers
per micrometer of basement membrane were estimated.
The slides were observed under light microscopy. Tissue
sections were examined with an Olympus BX40 micro-
scope in conjunction with an Olympus U-TV0.63XC
digital camera (Olympus BX53F, Center Valley, PA, USA).
To determine the percentage of PAS positive epithe-
lial cells, we divided number of PAS-positive by the
total cell epithelial cell number. Results are expressed
as percentage of PAS-positive cells per bronchiole for
each group of mice.
Statistical analysis
All results are expressed as the mean ± SEM. One-
way analysis of variance (ANOVA) was performed
using SPSS statistical software version 12.0 (SPSS Inc.,
Fig. 1 TEM images of SNPs. S-SNPs (a), M-SNPs (b), and P-SNPs (c). DLS analysis of S-SNPs (d), M-SNPs (e), and P-SNPs (f)
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Chicago, IL, USA). The AHR data were analyzed with
repeated-measures ANOVA followed by a post–hoc
Bonferroni test. The other data were analyzed with
one-way ANOVA followed by a post-hoc Bonferroni
test. P < 0.05 was considered statistically significant.
Results
Characterization of SNPs
S-SNPs and M-SNPs were spherical and mesoporous in
morphology, respectively. The P-SNPs were not different
from S-SNPs in terms of morphology. The M-SNPs were
globular in shape with multiple pores in each particle, com-
pared to S-SNPs which had no pores (Fig. 1a–c). Measured
by the BET equation method, the surface areas of S-SNPs
and M-SNP were 12.7 m2/g and 70.6 m2/g, respectively.
The surface area of P-SNPs was similar to that of S-SNPs.
In saline, the sizes of M-SNPs and S-SNPs were 100.5 ±
31.35 and 119.6 ± 45.33 nm (Fig. 1d–f), while the size of P-
SNPs in saline was 439.1 ± 54.64 nm on DLS analysis. The
DLS results showed that the sizes of the three SNPs in
D.W. were similar to about 100 nm (Data not shown).
Therefore, P-SNPs would aggregate after being diluted in
saline, and P-SNP aggregates had significantly larger sizes,
compared to other SNPs.
Detection of endotoxin
The endotoxin levels of all SNPs and OVA were below
0.1 EU/mg.
Direct toxic effects of SNPs
Intranasal administration of SNPs alone 3 times per
week for 2 weeks induced airway inflammation. M-SNPs
induced AHR to a significantly greater extent than
any other group. In contrast, S-SNPs and P-SNPs did
not induce significant AHR compared to the control
group (Fig. 3a). Total cell, macrophage and neutrophil
counts in SNP-treated groups were significantly higher than
those in control group. Especially, M-SNPs induced more
severe inflammation compared to S-SNPs and P-SNPs
(Fig. 3b). Histological analysis of lung did not showe peri-
bronchial and perivascular inflammation in all types of SNPs
treated groups compared to those in control group (Fig. 4).
In analysis of cytokine levels in lung tissues, we ob-
served significant increase of cytokine levels, including
IL-5, IL-13, IL-1β, and IFN-γ, in SNPs treated groups.
All types of SNPs induced significant increase of IL-5
compared to control group. However, there’s no signifi-
cant difference among all types of SNPs treated group.
The level of IL-13 significantly increased in M-SNPs
treated group compared to control group, and even
compared to the P-SNP-treated group. S-SNPs and P-
SNPs did not induce a significant increase of IL-13
compared to the control group. P-SNPs induced a sig-
nificantly lower increase of IL-13 compared to M-SNPs.
IL-1β levels were significantly increased in the S-SNP-
treated group compared to the control group and M-
SNP- and P-SNP-treated groups. IFN-γ levels were also
significantly increased in the M-SNP-treated group
compared to the control group. Although S-SNPs and
P-SNPs induced an increase in IFN-γ levels, the dif-
ference compared to the control group did not reach
statistical significance (p = 0.084) (Fig. 5).
Adjuvant effects of SNPs on allergic sensitization
Intranasal SNP/OVA administration induced significant
airway allergic inflammation. The P-SNP/OVA group
showed a similar result to the saline/OVA group. The
S-SNP/OVA and M-SNP/OVA groups showed signifi-
cant AHR compared to the control group and P-SNP/
OVA and saline/OVA groups. The P-SNP/OVA group
did not show significant AHR compared to the sa-
line/OVA group and control group. The saline/OVA
Fig. 2 Experimental design of chronic SNPs alone (a), and SNPs/OVA (b) in mice
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group also did not show AHR compared to the
control group. All SNP/OVA-treated groups showed a
greater extent of AHR than the SNP-treated group
(Fig. 6a).
The BALF analysis results showed the same pattern as
the AHR analysis. The number of total cells, macro-
phages, lymphocytes, eosinophils and neutrophils was
significantly increased in the S-SNP/OVA and M-SNP/
OVA groups compared to the P-SNP/OVA group,
saline/OVA group, and control group. Contrary to the
direct toxicity model, M-SNP/OVA and S-SNP/OVA in-
creased the number of not only total cells, macrophages,
and neutrophils but also eosinophils and lymphocytes
(Fig. 6b).
Histological analysis showed peribronchial and peri-
vascular inflammation in all SNP/OVA-treated groups.
In PAS staining, all SNP/OVA groups showed an in-
crease of goblet cell metaplasia. Especially the number
of PAS-positive divided by the total cell epithelial cell
number was significantly increased in the S-SNP/OVA
Fig. 4 Hematoxylin and eosin stain (H&E stain) and Periodic acid Schiff (PAS) stain was performed on lung sections of mice which exposed SNPs
alone. 30 μl saline (a, e), 200 μg S-SNPs (b, f), 200 μg M-SNPs (c, g), 200 μg P-SNPs (d, h)
Fig. 3 The effect of SNPs alone on the airway inflammation. Values are expressed as means ± SEM (*P < 0.05). Two-way ANOVA showed significant
increase for M-SNPs alone exposure on AHR (a). Significant increase for SNPs alone exposure on total cell, macrophage and neutrophil in BALF
(b). (n = 5 per group)
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Fig. 5 Cytokines were measured from lung homogenates of mice exposed SNPs alone. a IL-5, b IL-13, c IL-1β, d IFN-γ. Values are expressed as
means ± SEM (*P < 0.05). (n = 5 per group)
Fig. 6 The effect of SNPs/OVA on the airway inflammation. AHR was measured by methacholine in mice exposed SNPs/OVA (a). Total cell numbers
and number of macrophage, lymphocyte, eosinophil and neutrophil in BALF of mice exposed SNPs/OVA by intranasal (b). Values are expressed as
means ± SEM (*P < 0.05). (n = 5 per group)
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and M-SNP/OVA group compared to the control
group. However, the P–SNP/OVA group presented
less inflammation and less increase of goblet cell
metaplasia than the other SNP/OVA groups (Fig 7).
In the SNP/OVA-treated groups, the levels of cyto-
kines, including IL-5, IL-13, IL-1β and IFN-γ, was sig-
nificantly increased compared to the control group.
Particularly in the S-SNP group, the levels of IL-5 and
IL-1β were significantly increased compared to the
saline/OVA group. In the M-SNP group, the levels of
IL-1β and IFN-γ were significantly increased com-
pared to the saline/OVA group (Fig. 8).
Discussion
SNPs are mainly used in common applications such as cos-
metics and packaging, and they have recently used in drug
delivery systems. SNPs are believed to be safe for even the
human body [16]. However, the effects of exposure to SNPs
with or without other allergens on the respiratory system
are not well known. In this study, we demonstrated that
toxic effects and adjuvant effects of SNPs on the airway sys-
tem depended on their surface morphology in a murine
model. Although this study is similar to the Brabdenberger
et al. study in terms of the effects of co-exposure to OVA
and SNP on the development of allergic airway disease, we
aimed to investigate whether treatment of SNPs as only a
challenge without sensitization induces allergic airway in-
flammation, unlike the Brabdenberger et al. study [14].
In this study, SNPs were administered via six intrana-
sal injections of 200 μg over 2 weeks. The dose of SNPs
(200 μg/mouse) was determined on the basis of studies
on SNP toxicity in airway inflammation [9, 17]. Fur-
thermore, in our preliminary study, we evaluated the
effects of SNPs on airway inflammation by administra-
tion of two, four, and six times over 2 weeks. The
administration of SNPs for six times over 2 weeks
induced airway inflammation, whereas two and four ad-
ministrations did not (Data not shown). We determined
that this dose and frequency of SNP administration is
appropriate for visualizing the effects of SNPs on
airway inflammation in mice.
Inhalation exposure of SNPs showed toxic effects in
the airway system with exacerbation of significant
AHR, inflammatory cell increase in the BALF, peri-
bronchial inflammation in histological examination,
and increase of cytokine levels in lung tissue. Among all
Fig. 7 SNPs/OVA group induced airway inflammation compared to control. Hematoxylin and eosin stain (H&E stain) and Periodic acid Schiff (PAS)
stain was done on lung sections from mice exposed to SNPs/OVA. 30 μl saline (a, f), 20 μg saline/OVA (b, g), 200 μg S-SNPs/OVA (c, h), 200 μg
M-SNPs/OVA (d, i), 200 μg P-SNPs/OVA (e, j). Quantitation of inflammation cells was measured by Metamorph system
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types of SNPs, M-SNPs alone induced statistically signifi-
cant airway inflammation. The M-SNP-treated group
showed significantly increased AHR, inflammatory cell in-
crease in the BALF, and increased levels of IL-5, IL-13, IL-
1β, and IFN-γ. Therefore, that M-SNPs induce airway in-
flammation is likely to be associated with both Th1 immun-
ity (IL-1β and IFN-γ) and Th2 immunity (IL-5 and IL-13),
simultaneously [18, 19]. These results showed that M-SNPs
could induce airway inflammation, thus leading to remark-
able clinical improvement in the respiratory system.
Although M-SNPs induced significant AHR and in-
creased levels of IL-13, it is difficult to say that M-SNPs
induced typical asthmatic features in mice. M-SNPs did
not induce eosinophilic infiltration in the BALF or patho-
logic findings. M-SNPs also increased levels of IL-1β and
IFN-γ, which are associated with Th1 immunity. We
thus assume that M-SNPs induce nonspecific airway
inflammation associated with Th1 and Th2 immunity.
Though these results, we suggest that exposure to
SNPs alone is not sufficient to induce inflammatory
cell infiltration surrounding the bronchial tubes, but
it is still clearly toxic.
In the adjuvant effect model, SNPs showed an adju-
vant effect in development of allergic airway inflamma-
tion by OVA. Intranasal challenge with saline/OVA did
not induce allergic airway inflammation, however the
SNP/OVA-treated groups showed significant airway in-
flammation, remarkable AHR, increased inflammatory
cell counts in the BALF, perivascular/peribronchial
inflammation in histopathology, and increased levels of
various cytokines compared to the saline/OVA-treated
group. Contrary to the SNP-alone model, the SNP/
OVA-treated group presented more significant AHR and
inflammatory cell infiltration, including eosinophils. Eo-
sinophil infiltration is a specific finding of typical asthma
associated with Th2 immunity [20, 21]. These findings
support that SNPs have an adjuvant effect for OVA in
the induction of airway inflammation. However, the
grade of eosinophilic infiltration in SNP/OVA-treated
model was lower than that in a typical asthma model.
The levels of Th1-associated cytokines (IL-1β and IFN-γ)
also increased in the SNP/OVA-treated group. Although
SNPs act as an adjuvant to OVA to induce allergic
airway inflammation, their effect is not sufficient to
Fig. 8 Cytokines were measured from lung homogenates of mice exposed SNPs/OVA. IL-5 (a), IL-13 (b), IL-1β (c), IFN-γ (d). Values are expressed
as means ± SEM (*P < 0.05). (n = 5 per group)
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induce pure allergic inflammation in comparison with
another typical allergens, such as OVA.
Some molecules such as particulate matter (PM)
and pollutants are known to have adjuvant effects for
allergic sensitization and to induce allergic inflamma-
tion in conditions with exposure to typical allergens
[22]. Some patients who are exposed to typical aller-
gens but have no allergic disease could develop aller-
gic diseases if they are exposed to typical allergens in
the presence of adjuvants such as PM and pollutants.
Because SNPs also have an adjuvant effect for induc-
tion of allergic airway inflammation by OVA similar
to these molecules, SNPs may induce allergic disease
in patients who have no allergic disease in the pres-
ence of typical allergens.
In both models of the present study, P-SNPs treatment
induced less inflammation. The contact area is a critical
factor for inducing toxicity during interaction between
SNPs and lung tissue. Large surface area is useful for
drug delivery, labeling, and gene delivery [23]. However,
a smaller surface area results in less opportunity for
tissue interaction and thus less inflammation when SNPs
are absorbed via the intranasal route [8, 24, 25]. There-
fore, we suggest that the larger surface area of M-SNPs
could induce more severe inflammation than that
induced by other SNPs.
Although S-SNPs and P-SNPs have a similar diameter
and surface area, P-SNPs induced airway inflammation
to a lesser extent than S-SNPs. These results may be
due to the aggregation characteristic of P-SNPs due
to their surface coating; S-SNPs and M-SNPs were
dispersed. Some studies have been reported that aggre-
gated forms of nanoparticles show less toxicity than
dispersed nanoparticles [26, 27]. In this study, P-SNPs
suspended in D.W. were not aggregated, while those sus-
pended in saline were. Therefore, we raise the possibility
that P-SNPs are less toxic owing to their surface area and
propensity to aggregate. However, further studies are
needed to assess toxicity of P-SNPs in relation to aggrega-
tion and dispersion patterns in more detail.
In summary, the results of our study indicate that
SNPs alone and SNPs with OVA can induce airway
inflammation in mice. These findings suggest that ex-
posure to SNPs alone might enhance airway diseases,
such as asthma. The toxicity of SNPs may different
depending on their coatings and dispersion patterns. We
suggest that P-SNPs might be safer than S-SNPs and
M-SNPs for medical applications in humans.
Conclusions
Exposure to SNPs alone and SNPs/OVA resulted in toxicity
in the airway system. Our data suggest also that SNPs have
adjuvant effect for OVA to induce allergic airway inflamma-
tion. Notably, M-SNPs showed the most severe airway
inflammation in both the direct toxicity and adjuvant effect
assays. P-SNP appeared to be less harmful than other SNPs
to the airway system.
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